Selatox Secures BPOM Export Approval for Indonesian Botulinum Toxin
- Indonesian biopharmaceutical company Selatox has secured BPOM export-related marketing authorisation for its locally manufactured botulinum toxin product. The approval marks a step towards international market entry as the company expands its manufacturing, research and development capabilities in Indonesia.











